Как победить диабет. Руководство по питанию и образу жизни

3. Chia JSJ, McRae JL, Kukuljan S, et al. A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes. Nutr Diabetes. 2017; 7(5): e274.

4. Pozzilli P, Pieralice S. Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metab. 2018; 33(2): 147.

5. Taylor R. Banting Memorial Lecture 2012. Reversing the twin cycles of Type 2 diabetes. Diabet Med. 2013; 30(3): 267–275.

6. Accili D, Talchai SC, Kim-Muller JY, et al. When b-cells fail: lessons from dedifferentiation. Diabetes, Obes Metab. 2016; 18(April): 117–122.

7. Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of Type 1 and Type 2 diabetes Among Children and Adolescents From 2001 to 2009. JAMA. 2014; 311(17): 1778.

8. Rodrigo N, Glastras S. The emerging role of biomarkers in the diagnosis of gestational diabetes mellitus. J Clin Med 2018, Vol 7. 2018; 7(6): 120.

9. CDC. Gestational Diabetes | Basics | Diabetes | CDC. Cdc. 2017. URL: https://www.cdc.gov/diabetes/basics/gestational.html.

10. American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in Diabetes-2018. Diabetes Care. 2018; 41 (January): S13–S27.

11. Rosenquist KJ, Fox CS. Chapter 36: Mortality Trends in Type 2 diabetes. Diabetes Am. 2009; 1–14. URL: https://www.niddk.nih.gov/ about-niddk/strategic-plans-reports/Documents/Diabetes in America 3rd Edition/DIA_Ch36.pdf.

12. American Heart Association. Cardiovascular Disease and Diabetes | American Heart Association. URL: http://www.heart.org/en/health-topics/diabetes/why-diabetes-matters/cardiovascular-disease-diabetes. Published 2015. Accessed August 31, 2018.

13. Chen H-F, Ho C-A, Li C-Y. Risk of heart failure in type 2 diabetes population: Comparison with non-diabetes subjects with and without coronary heart diseases. Diabetes, Obes Metab. 2019; 1:12–119.

14. Boyko EJ, Monteiro-Soares M, Wheeler SGB. Chapter 20: Peripheral Arterial Disease, Foot Ulcers, Lower Extremity Amputations, and Diabetes. Cowie CC, Casagrande SS, Menke A, et al. eds. Diabetes in America. 3rd ed. Bethesda, MD: National Institues of Health, NIH Pb No. 17–1468; 2017. Chap. 20.

15. Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 diabetes Mellitus. J Manag Care Spec Pharm. 2018; 24(9-a Suppl): S5–S13.

16. Yeh H, Golozar A, Brancati FL. Cancer and diabetes. Cowie CC, Casagrande SS, Menke A, et al. eds. Diabetes in America. 3rd ed. Bethesda, MD: National Institutes of Health, NIH Pb No. 17–1468; 2017. Chap. 29.

17. Restifo D, Williams JS, Garacci E, et al. Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults. J Diabetes Complications. 2018; 32(9): 819–823.

18. Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract. 2017;124: 41–47.

19. Willis JR, Doan QV, Gleeson M, et al. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States. JAMA Ophthalmol. 2017; 135(9): 926–932.

20. Xu Y, Zhang Y, Yang Y, et al. Prevalence and correlates of erectile dysfunction in type 2 diabetic men: a population-based cross-sectional study in Chinese men. Int J Impot Res. 2019; 31(1): 9–14.

21. Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015; 75(6): 577–587.

22. World Health Organization. Waist Circumference and Waist-Hip Ratio: Report ofaWHOExpertConsultation. 2008; Geneva: 8–11.

23. Johnson AMF, Olefsky JM. The origins and drivers of insulin resistance. Cell. 2013; 152(4): 673–684.

24. Nicholson T, Church C, Baker DJ, Jones SW. The role of adipokines in skeletal muscle inflammation and insulin sensitivity. J Inflamm (United Kingdom). 2018; 15(1): 1–11.

25. Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. In J Endocrinol. 2015; 2015: 508409.

26. Agrawal NK. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes. 2014; 5(5): 697.

27. Odegaard AO, Jacobs DR, Sanchez OA, et al. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016; 15(1): 1–12.

28. Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015; 5(1): 194–222.

29. Morales PE, Bucarey JL, Espinosa A. Muscle lipid metabolism: Role of lipid droplets and perilipins. J Diabetes Res. 2017; 2017: 1789395.